Author:
Tsurutani Junji,Nitta Takashi,Hirashima Tomonori,Komiya Takefumi,Uejima Hisao,Tada Hirohito,Syunichi Negoro,Tohda Aritomo,Fukuoka Masahiro,Nakagawa Kazuhiko
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference22 articles.
1. Irinotekan in small-cell lung cancer-Japanese trials;Fukuoka;Oncology,2000
2. A phase II study of irinotecan combined with cisplatin in non-small cell lung cancer;Nagao;Gan To Kagaku Ryoho,2000
3. Salts LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ, for the Irinotecan Study Group. Irinotecan plus fluorouracil and leucovorin for metasitatic colorectal cancer. New Engl J Med 2000;243(13):905–914.
4. Mutation at the catalytic site of topoisomerase I CEM/C2, a human leukemia cell line resistant to camptothecin;Fujimori;Cancer Res.,1995
5. Identification of a mutant topoisomerase I with intact catalatic activity and resistance to 9-nitrocamptothecin;Rubin;J. Biol. Chem.,1994
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献